Cosmo shareholders approved Board proposal to appoint new independent auditor at today’s EGM

· Cosmo Pharmaceuticals NV

Cosmo shareholders today approved the proposal by the Board of Directors to appoint Deloitte Accountants B.V. as new independent auditor of the Company for the financial year ending on 31 December 2024.

Download press release (PDF)

← All news